As of 2026-04-04, the EV/EBITDA ratio of TRACON Pharmaceuticals Inc (TCON) is
-0.76.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TCON's latest enterprise value
is -7.78 mil USD. TCON's TTM EBITDA according to its financial statements is
10.20 mil USD. Dividing these 2
quantities gives us the above TCON EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
11.4x - 14.3x |
14.1x |
| Forward P/E multiples |
14.2x - 18.4x |
16.4x |
| Fair Price |
863.09 - 2,004.07 |
1,475.35 |
| Upside |
60256.3% - 140044.5% |
103071.2% |